Zum Inhalt springen

GALDERMA GRP AG

201,00€ -12,00 (-5,63%) 19.11.2026, 22:59:15 Uhr
WKN: A407X6 ISIN: CH1335392721 Wertpapiertyp: Aktie Währung: Euro
  • 1T
  • 1W
  • 1M
  • 3M
  • 6M
  • 1J
  • 3J
  • 5J
  • 10J
  • Max

Zuletzt angesehen

Kursperformance

Zeitraum Kurs %
1 Tag 213,00€ -5,63%
1 Woche 216,61€ -1,67%
1 Monat 195,89€ +8,73%
6 Monate 178,42€ +19,38%
Lfd. Jahr (YTD) 182,26€ +16,87%
1 Jahr 165,08€ +29,03%
3 Jahre -- --
5 Jahre -- --

Kursdaten

Kurs 201,00€
Schluss Vortag 213,00€
Eröffnung 201,00€
Geld 0,00€
Brief 0,00€
Tages-Hoch 201,00€
Tages-Tief 201,00€
52 Wochen-Hoch 213,35€
52 Wochen-Tief 149,40€
Allzeit-Hoch 213,35€
Allzeit-Tief 111,00€

Nachrichten

  • BUSINESS WIRE: Mexico Becomes the First Market Worldwide to Receive Approval for Galderma’s Restylane® Shaype™ for Both Chin and Its First Jawline Indication - 13.11.2026, 07:00:03 Uhr
  • BUSINESS WIRE: Galderma Announces Proposed Board Appointments and Chief Financial Officer Transition - 02.11.2026, 18:00:05 Uhr
  • BUSINESS WIRE: Galderma’s Relfydess™ (relabotulinumtoxinA) Receives Approval in China for Frown Lines - 23.10.2026, 07:00:02 Uhr
  • BUSINESS WIRE: Galderma Delivers Net Sales of 4.765 B USD in the First Nine Months, Up 25.1% at Constant Currency Year-on-Year, and Raises Full-Year Net Sales Guidance - 22.10.2026, 07:00:07 Uhr
  • BUSINESS WIRE: AMWC Dubai 2026: Galderma Reinforces Its Injectable Aesthetics Leadership - 21.10.2026, 07:00:04 Uhr
  • BUSINESS WIRE: PeDRA 2026: Nemolizumab Phase II Data Show Long-Term Symptom Relief for Children Aged 2 to 11 Years With Moderate-to-Severe Atopic Dermatitis - 15.10.2026, 07:00:03 Uhr
  • BUSINESS WIRE: Galderma Signs Agreement to Acquire ZO Skin Health, Strengthening Its Physician-Dispensed Skincare Offering - 14.10.2026, 07:00:05 Uhr
  • BUSINESS WIRE: New Galderma Research Reveals More Than Half of Women Mistake Menopause-Related Skin Changes for Signs of Ageing - 13.10.2026, 07:00:06 Uhr
  • BUSINESS WIRE: Fall Clinical 2026: Galderma Presents New Three-Year Nemluvio® Data Showing Deep and Lasting Skin Lesion and Itch Responses in Patients With Atopic Dermatitis Aged 12 and Older - 08.10.2026, 07:00:07 Uhr
  • BUSINESS WIRE: 30 Years of Restylane®: Reshaping the Aesthetics Field Through Science-Led, Patient-Centric Innovation - 06.10.2026, 07:00:03 Uhr
Ein Angebot der manager-Gruppe mit Daten von Infront.